| 1. |
Clarke BL, Brown EM, Collins MT, et al. Epidemiology and diagnosis of hypoparathyroidism. J Clin Endocrinol Metab, 2016, 101(6): 2284-2299.
|
| 2. |
Orloff LA, Wiseman SM, Bernet VJ, et al. American thyroid association statement on postoperative hypoparathyroidism: diagnosis, prevention, and management in adults. Thyroid, 2018, 28(7): 830-841.
|
| 3. |
Shoback D. Clinical practice. Hypoparathyroidism. N Engl J Med, 2008, 359(4): 391-403.
|
| 4. |
Anastasiou OE, Yavropoulou MP, Papavramidis TS, et al. Secretory capacity of the parathyroid glands after total thyroidectomy in normocalcemic subjects. J Clin Endocrinol Metab, 2012, 97(7): 2341-2346.
|
| 5. |
Nawrot I, Wo?niewicz B, To??oczko T, et al. Allotransplantation of cultured parathyroid progenitor cells without immunosuppression: clinical results. Transplantation, 2007, 83(6): 734-740.
|
| 6. |
Johansson K, Ander S, Lennquist S, et al. Human parathyroid blood supply determined by laser-Doppler flowmetry. World J Surg, 1994, 18(3): 417-420.
|
| 7. |
Jiang H, Shen H, Jiang D, et al. Evaluating the safety of the Harmonic Scalpel around the recurrent laryngeal nerve. ANZ J Surg, 2010, 80(11): 822-826.
|
| 8. |
Lo CY, Lam KY. Postoperative hypocalcemia in patients who did or did not undergo parathyroid autotransplantation during thyroidectomy: a comparative study. Surgery, 1998, 124(6): 1081-1087.
|
| 9. |
Palazzo FF, Sywak MS, Sidhu SB, et al. Parathyroid autotransplantation during total thyroidectomy—does the number of glands transplanted affect outcome? World J Surg, 2005, 29(5): 629-631.
|
| 10. |
Sitges-Serra A, Ruiz S, Girvent M, et al. Outcome of protracted hypoparathyroidism after total thyroidectomy. Br J Surg, 2010, 97(11): 1687-1695.
|
| 11. |
Singer MC, Bhakta D, Seybt MW, et al. Calcium management after thyroidectomy: a simple and cost-effective method. Otolaryngol Head Neck Surg, 2012, 146(3): 362-365.
|
| 12. |
Wang TS, Cheung K, Roman SA, et al. To supplement or not to supplement: a cost-utility analysis of calcium and vitamin D repletion in patients after thyroidectomy. Ann Surg Oncol, 2011, 18(5): 1293-1299.
|
| 13. |
Terris DJ, Snyder S, Carneiro-Pla D, et al. American thyroid association statement on outpatient thyroidectomy. Thyroid, 2013, 23(10): 1193-1202.
|
| 14. |
Gentileschi P, Gacek IA, Manzelli A, et al. Early (1 hour) post-operative parathyroid hormone (PTH) measurement predicts hypocalcaemia after thyroidectomy: a prospective case-control single-institution study. Chir Ital, 2008, 60(4): 519-528.
|
| 15. |
McCullough M, Weber C, Leong C, et al. Safety, efficacy, and cost savings of single parathyroid hormone measurement for risk stratification after total thyroidectomy. Am Surg, 2013, 79(8): 768-774.
|
| 16. |
Stack BC Jr, Bimston DN, Bodenner DL, et al. American association of clinical endocrinologists and American college of endocrinology disease state clinical review: postoperative hypoparathyroidism—definitions and management. Endocr Pract, 2015, 21(6): 674-685.
|
| 17. |
Hansen KE, Jones AN, Lindstrom MJ, et al. Do proton pump inhibitors decrease calcium absorption? J Bone Miner Res, 2010, 25(12): 2786-2795.
|
| 18. |
Singh N, Singh PN, Hershman JM. Effect of calcium carbonate on the absorption of levothyroxine. JAMA, 2000, 283(21): 2822-2825.
|
| 19. |
Mannstadt M, Bilezikian JP, Thakker RV, et al. Hypoparathyroidism. Nat Rev Dis Primers, 2017, 3: 17055.
|
| 20. |
Shoback DM, Bilezikian JP, Costa AG, et al. Presentation of hypoparathyroidism: etiologies and clinical features. J Clin Endocrinol Metab, 2016, 101(6): 2300-2312.
|
| 21. |
Bilezikian JP, Khan A, Potts JT Jr, et al. Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. J Bone Miner Res, 2011, 26(10): 2317-2337.
|
| 22. |
Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab, 2011, 96(7): 1911-1930.
|
| 23. |
關海霞. 術后甲狀旁腺功能減退的內科治療. 中國實用外科雜志, 2014, 34(4): 317-320.
|
| 24. |
Bollerslev J, Rejnmark L, Marcocci C, et al. European Society of Endocrinology Clinical Guideline: treatment of chronic hypoparathyroidism in adults. Eur J Endocrinol, 2015, 173(2): G1-G20.
|
| 25. |
Brandi ML, Bilezikian JP, Shoback D, et al. Management of Hypoparathyroidism: Summary Statement and Guidelines. J Clin Endocrinol Metab, 2016, 101(6): 2273-2283.
|
| 26. |
中華醫學會骨質疏松和骨礦鹽疾病分會, 中華醫學會內分泌分會代謝性骨病學組. 甲狀旁腺功能減退癥臨床診療指南. 中華骨質疏松和骨礦鹽疾病雜志, 2018, 11(4): 323-338.
|
| 27. |
Mannstadt M, Clarke BL, Vokes T, et al. Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study. Lancet Diabetes Endocrinol, 2013, 1(4): 275-283.
|
| 28. |
Cusano NE, Rubin MR, McMahon DJ, et al. The effect of PTH(1-84) on quality of life in hypoparathyroidism. J Clin Endocrinol Metab, 2013, 98(6): 2356-2361.
|
1/5
WeChat